At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 403 enrolled
Drug / intervention
Meloxicam Test Capsules +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Fixed-Dose, Parallel-Group, Efficacy, and Safety Study of Meloxicam SoluMatrix™ Capsules in Patients With Pain Due to Osteoarthritis of the Knee or Hip
In Brief
A Phase 3 clinical trial evaluating Meloxicam Test Capsules and Placebo Capsules for Osteoarthritis. Completed, enrolled 403 participants across 40 sites.
Detailed Summary
The purpose of this study is to determine whether Meloxicam \[Test\] Capsules are safe and effective for the treatment of osteoarthritis pain of the knee or hip.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedFeb 2013
Primary CompletionOct 2013
TodayJul 2026
First PostedFeb 8, 2013
Enrollment StartFeb 1, 2013
Primary CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 13.4 years ago
Interventions
Meloxicam Test Capsulesdrug
Meloxicam Test Capsulesdrug
Placebo Capsulesdrug